Alison joined CellCentric in March 2025.

Alison is an experienced general counsel in the biotech and pharma sector.  She was previously VP & Head of Legal, International at Aimmune Therapeutics, with responsibility for all legal activities outside the U.S. and a member of the EU executive team. She led the EU legal function supporting the clinical, regulatory and commercial teams and the expansion of the EU business from its original UK base to include offices in Ireland, Germany, France and Switzerland and was closely involved in the integration of Aimmune into Nestlé Health Science following acquisition in 2020.

Alison holds a BSC Hons in Biochemistry from the University of London and an MSc in Intellectual Property Law from Queen Mary, University of London.  After spending her early career as a research scientist in Australia, she then qualified as a solicitor and worked in private practice for a number of years, specializing in IP and technology, after which she moved in-house and worked as Associate General Counsel at Celltech pls and General Counsel at Vernalis plc.